Simeon Pollack. The rationale for using hydroxycarbamide in the treatment of sickle cell disease” (Haematologica 2011;96:488–491). Reply. Haematologica 2011;96(6):e30-e30; https://doi.org/10.3324/haematol.2011.046409.